Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 14, 2020
Neurocrine Biosciences and Idorsia announced an amendment to the agreement granting Neurocrine Biosciences an option to license ACT-709478 for a rare pediatric epilepsy.
read more
Charles River announced a multi-year drug discovery collaboration with Takeda Pharmaceutical.
read more
Biomica has entered a service agreement with Biose Industrie for the scale-up production of its drug candidates, microbial consortia BMC121 & BMC127 for its Immuno-Oncology program.
read more
Adare and NLS announced a collaboration to develop mazindol CR product candidates for the treatment of narcolepsy and ADHD.
read more
MediWound announced the expansion of its agreement with GENFA MEDICA, granting it the exclusive right to market and distribute NexoBrid® in Ukraine, Lithuania, Latvia, and Estonia.
read more
Altasciences announced the addition of Paul Sidney to their Compliance and Regulatory Affairs team as Senior Director.
read more
Horizon Discovery has signed a collaboration and license agreement with Mammoth Biosciences to access Mammoth’s novel CRISPR platform.
read more
Codexis and Nestlé Health Science have signed an agreement to advance a lead candidate discovered through a SCA into preclinical development and early clinical studies.
read more
Contract Pharmacal plans to expand into a new space on Long Island, New York.
read more
Avid Bioservices announced the appointment of Timothy Compton as chief commercial officer.
read more
PhaseBio announced a financing and co-development collaboration with SFJ Pharmaceuticals to support the development of PB2452, a reversal agent for the antiplatelet therapy ticagrelor.
read more
Thursday, January 09, 2020
Gilead Sciences announced the company has licensed The Rockefeller University’s portfolio of broadly neutralizing antibodies (bNAbs) against HIV, including the two clinical-stage agents 3BNC117 and 10-1074.
read more
Thursday, January 09, 2020
PPD has expanded its operations and leadership team in China to provide enhanced clinical development, laboratory, regulatory, site conduct, patient access and post-approval services for international and China-based biopharmaceutical companies.
read more
Thursday, January 09, 2020
The Clarke Companies has added Covex to its portfolio of businesses.
read more
Thursday, January 09, 2020
Verastem announced a global licensing agreement with Chugai Pharmaceutical.
read more